NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, announced that the underwriter of its recent public offering exercised its option to purchase an additional 864,033 shares at $1.70 per share. This move increases the total gross proceeds from the offering to approximately $11.5 million, before deductions. The exercise of the over-allotment option closed Feb. 25, 2025, following the initial 5,882,353 share offering that closed Feb. 14, 2025. The funds will support HeartBeam’s strategic growth initiatives, including U.S. commercialization efforts, R&D, and regulatory projects. MDB Capital served as the underwriter, with Paulson Investment Company LLC acting as a selected dealer.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer